Skip to main content

Table 4 Results of this analysis

From: Head to head comparison of Prasugrel versus Ticagrelor in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized trials

Outcomes analyzed No of studies involved OR with 95% CI P value I2 (%)
Mortality 4 1.52 [0.42 – 5.45] 0.52 0
MI 2 0.59 [0.08 – 4.58] 0.62 0
MACEs 4 0.91 [0.37 – 2.21] 0.83 0
Stroke 3 0.60 [0.08 – 4.58] 0.62 0
ST 2 0.59 [0.08 – 4.58] 0.62 0
Any bleeding 4 1.30 [0.64 – 2.64] 0.47 37
TIMI minor bleeding 2 3.11 [0.48 – 19.94] 0.23 1
TIMI minimal bleeding 2 2.39 [0.35 – 16.42] 0.38 0
BARC defined bleeding 2 0.92 [0.39 – 2.13] 0.84 0
  1. Abbreviations: MI myocardial infarction, MACEs major adverse cardiac events, ST stent thrombosis, TIMI thrombolysis in myocardial infarction, BARC bleeding defined by the academic research consortium, OR odds ratios, CI confidence intervals